Teva Branded Pharmaceutical Products R&D LLC — Sponsor Intelligence | 12 EU Trials

Filter these 12 trials by condition, phase, country and more.

Open in Search →

12 Registered trials

3 Recruiting

9 Completed trials

19 Countries active

7 Unique IMPs

100% Results reported

Phase III

Phase II

Phase I (Other)

Phase III: 3 Phase II: 5 Phase I (Other): 4

100%

9 of 9 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Asthma 2 Schizophrenia 1 Pruritus 1 Multiple system atrophy 1

Top IMPs

DUVAKITUG 2 EMRUSOLMIN 2 FLUTICASONE PROPIONATE, SALBUTAMOL SULFATE 2 SALBUTAMOL SULFATE 2 FLUTICASONE PROPIONATE 1 FREMANEZUMAB 1 TEV-53408 1

All trials

12 total

An Open-Label Extension, Multi-Centered, Phase 2 Trial of TEV-56286 (Emrusolmin) for Multiple System Atrophy Recruiting

2025-521642-14-00 Phase II 4 countries EMRUSOLMIN
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Parti… Recruiting

2024-517991-39-00 Phase III 6 countries FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE, SALBUTAMOL SULFATE; SALBUTAMOL S…
A Multi-centered, Double-blind, Randomized, Placebo-controlled Study of TEV-56286 for the Treatment of Multiple System Atrophy Recruiting

2023-505320-54-00 Phase II 4 countries EMRUSOLMIN
A Phase 2a Trial to Characterize the Efficacy and Safety of TEV-53408 in Adults with Celiac Disease Ended

2024-517081-42-00 Phase II 1 country TEV-53408
A Randomized, Double Blind, Active-Controlled Study on Efficacy and Safety of TEV-56248 in Patients with Asthma Ended

2023-505435-12-00 Phase III 12 countries FLUTICASONE PROPIONATE, SALBUTAMOL SULFATE; SALBUTAMOL SULFATE
A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn’s Disease Ended

2024-515027-11-00 Phase II 10 countries DUVAKITUG
A Phase 1 Open-Label Mass Balance clinical trial to Investigate the Absorption, Metabolism, and Excretion of Single Oral Administration of [… Ended

2024-515556-20-00 Phase I (Other) 1 country
An Open-Label Trial to Assess the Comparative Bioavailability of TV-44749 to Oral Olanzapine in Participants with Schizophrenia Ended

2023-505664-11-00 Phase I (Other) 4 countries
A Phase 1b Study to Characterize the Safety and Tolerability of TEV-53408 in Adults with Celiac Disease Ended

2022-502817-27-00 Phase I (Other) 1 country
Double-Blind, Randomized, Placebo-Controlled, Phase 1b, Pharmacodynamic Trial of TEV-56192 Following a Single Intravenous Administration in … Ended

2023-507018-29-00 Phase I (Other) 1 country
A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn’s Disease Ended

2024-511089-36-00 Phase II 12 countries DUVAKITUG
A Trial to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents Ended

2024-512837-34-00 Phase III 6 countries FREMANEZUMAB

Showing 1–12 of 12 trials

← All sponsors A–Z